-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
Topics
Meeting category
Program Language
English
Organizer
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases
General
What's New
Welcome
With more than 100 monoclonal antibiotics (mAbs) in use, harnessing this technology has advanced therapeutic development for COVID-19 and underscored their utility and versatility to respond rapidly to emerging global health threats.
Recent approvals and recommendations for mAbs in preventing and treating RSV and Ebola offer novel tools to control these (re) emerging viruses.
They also offer new avenues for preventing bacterial and parasitic infections, such as Clostridium difficile and Plasmodium falciparum (causative agent of malaria tropica in humans).
Those advances come hand-in-hand with educational needs to comprehend technology, pharmacological properties, challenges for equitable access, and recent clinical data.
In contrast to existing programs, this workshop provides a platform for cross-disciplinary discussion, catalyzes knowledge transfer, and prompts discussions on remaining unknowns to ultimately move the field forward.
Program Directors
Charles Flexner, MD
Johns Hopkins University School of Medicine, United States
Daniel Kuritzkes, MD
Brigham and Women's Hospital; Harvard Medical School, United States
General Information
Uniques Features
- Clinical utility of monoclonal antibodies for IDs
- Interactive case presentations
- Cross-disciplinary discussion
- Interactive case presentations
- Cross-disciplinary discussion
Who Should Attend?
- Infectious disease doctors
- Researchers, microbiologists, virologists, immunologists
- Pharmacologists
- Nurses, pharmacists
- Healthcare administrators
- Policymakers, and (non)government representatives
- Researchers, microbiologists, virologists, immunologists
- Pharmacologists
- Nurses, pharmacists
- Healthcare administrators
- Policymakers, and (non)government representatives
Meeting Objectives
This meeting aims to:
- Provide a platform to summarize key data on the clinical utility of monoclonal antibodies for the prevention and treatment of infectious disease.
- Strengthen education on the monoclonal antibody-based therapeutics for infectious diseases among healthcare professionals, researchers, and policymakers.
- Stimulate cross-disciplinary discussion on the clinical relevance of monoclonal antibody-based therapeutics in the context of public health emergencies and rethinking the approaches for conditions that are currently challenging to treat or prevent.
- Provide a platform to summarize key data on the clinical utility of monoclonal antibodies for the prevention and treatment of infectious disease.
- Strengthen education on the monoclonal antibody-based therapeutics for infectious diseases among healthcare professionals, researchers, and policymakers.
- Stimulate cross-disciplinary discussion on the clinical relevance of monoclonal antibody-based therapeutics in the context of public health emergencies and rethinking the approaches for conditions that are currently challenging to treat or prevent.
Learning Objectives
After participating in this activity, participants will be able to:
- Summarize the latest clinical data on the use of monoclonal antibodies for the prevention and treatment of infectious diseases.
- Comprehend key clinical considerations for the use of monoclonal antibodies in different priority populations (e.g. pediatrics, immunocompromised patients).
- Discuss the impact of microbial molecular evolution on the clinical utility of monoclonal antibodies.
- Reflect on barriers and opportunities for equitable access to mAb-based therapeutics.
- Summarize the latest clinical data on the use of monoclonal antibodies for the prevention and treatment of infectious diseases.
- Comprehend key clinical considerations for the use of monoclonal antibodies in different priority populations (e.g. pediatrics, immunocompromised patients).
- Discuss the impact of microbial molecular evolution on the clinical utility of monoclonal antibodies.
- Reflect on barriers and opportunities for equitable access to mAb-based therapeutics.
Practical Information
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-conference survey.
Language
The official language of the conference is English
Translation will not be provided.
Translation will not be provided.
Enduring Materials
Enduring materials will be available to all registered delegates on the virtual conference portal for 3 weeks after the conference. After this, all presentations will be made publicly available on this website (pending the approval of the speakers)
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Fees and Conditions
|
Regular Delegates In Person |
Regular Delegates Virtual |
Industry In Person |
Industry Virtual |
|
|---|---|---|---|---|
|
Early Fee |
€395 |
€295 |
€595 |
€495 |
|
Standard Fee |
€595 |
€495 |
€795 |
€695 |
|
Same Day Fee |
€695 |
€595 |
€895 |
€795 |
|
Discounts |
|
|---|---|
|
Early-Career Investigators / Regular Delegates from Resource-Limited Settings (RLS)* WITH an accepted abstract |
Complimentary Registration |
|
Early-Career Investigators / Regular Delegates from Resource-Limited Settings (RLS)* WITHOUT an accepted abstract |
50% Off Current Regular Delegates Fee |
|
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates |
50% Off Current Regular Delegates Fee |
|
Members of Endorsers |
25% Off Current Regular Delegates Fee |
|
Sponsors |
Contact Secretariat |
If eligible for a discount, please contact the conference secretariat at catherine.phan@amededu.com
*Countries included in the low-income and middle-income economies list of the World Bank Classification
Important
-
We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
Registration Fee Includes
- Access to all scientific sessions
- Digital workshop pack, including the program
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Digital workshop pack, including the program
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please use the Group Registration Portal.
Early-Career Investigators / Academia from Resource-limited Settings (RLS)
We are pleased to waive the registration fee for early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract and a 50% discount on the registration fee without an accepted abstract.
IMPORTANT: The fee waiver is offered to the presenting author only.
To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
IMPORTANT: The fee waiver is offered to the presenting author only.
To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Payment
By credit card only: online or by written authorization (see online registration).
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the Conference, the conference secretariat needs to receive:
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2020 embargo policy.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2020 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Program
Preliminary Program
The program is currently under development.
The program of International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023 can be found here: https://academicmedicaleducation.com/meeting/international-workshop-monoclonal-antibodies-treatment-prevention-infectious-diseases-2023
Committees
Program Directors
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Support
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in HIV and co-infections with HIV.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Rikke Puggaard-Rode at rikke.rode@amededu.com.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Previous Editions
Language
Related Programs
